A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
Clinical trial NCT06764303 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06764303
- Sponsor
- Nanjing Chia-tai Tianqing Pharmaceutical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-23
- Primary completion
- 2025-07-08
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.